Biogen's most recent trend suggests a bearish bias. One trading opportunity on Biogen is a Bear Call Spread using a strike $290.00 short call and a strike $295.00 long call offers a potential 25% return on risk over the next 9 calendar days. Maximum profit would be generated if the Bear Call Spread were to expire worthless, which would occur if the stock were below $290.00 by expiration. The full premium credit of $1.00 would be kept by the premium seller. The risk of $4.00 would be incurred if the stock rose above the $295.00 long call strike price.
The 5-day moving average is moving down which suggests that the short-term momentum for Biogen is bearish and the probability of a decline in share price is higher if the stock starts trending.
The 20-day moving average is moving down which suggests that the medium-term momentum for Biogen is bearish.
The RSI indicator is at 36.02 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Biogen
7:06 am Biogen Idec and Sobi announce positive top-line efficacy and safety results from Phase 3 pediatric study of investigational therapy eloctate (rFVIIIFc) for hemophilia A; data showed twice-weekly prophylactic dosing with ELOCTATE mai
Fri, 11 Apr 2014 11:06:00 GMT
Hemophilia drug draws plaudits
Thu, 10 Apr 2014 22:49:00 GMT
Nasdaq plunges 3%; Dow closes down 267 points
Thu, 10 Apr 2014 21:00:46 GMT
Stocks crushed as previous days gains wiped out
Thu, 10 Apr 2014 20:18:28 GMT
Biotech IPOs Adamas, Cerulean Slump In Trading Debut
Thu, 10 Apr 2014 20:02:00 GMT
Related Posts
Also on Market Tamer…
Follow Us on Facebook